The Pharmaceutical Market as Reflected by Patents
December 2011
in “
Drug Research
”
TLDR The document shows the state of pharmaceutical patents as of 1999, focusing on treatments for various diseases.
The document from 2011 reviews patented pharmaceutical compounds and their applications in treating a range of medical conditions, with a focus on ocular disorders, CNS, cardiovascular, gastrointestinal, neurodegenerative diseases, and skin-related diseases including alopecia. It details the chemical structures, uses, synthesis, and biological data of these compounds, which include adrenoceptor modulators, neuroprotective agents, and others. Specific patents are highlighted for treatments of proliferative disorders, psoriasis, and alopecia, with companies like Allergan Inc., Rhône Poulenc Rorer International Holdings, and Yamanouchi Pharmaceutical Co. Ltd. holding patents for compounds with dosages and administration methods described. The document aims to assist in marketing and scientific efforts by reflecting the state of pharmaceutical patent filings as of 1999.
